Table 5.
Sensitivity analysis of transferrin for predicting 28- and 90-day mortality
| Treatment arm | OR | 95% CI | P |
|---|---|---|---|
| 28-day mortality | |||
| Placebo-placebo | 0.967 | 0.952–0.982 | <0.0001 |
| Prednisolone | 0.991 | 0.982–1.000 | 0.0493 |
| Pentoxifylline | 0.988 | 0.981–0.996 | 0.00385 |
| Prednisolone and pentoxifylline | 0.983 | 0.972–0.994 | 0.00348 |
| 90-day mortality | |||
| Placebo-placebo | 0.987 | 0.979–0.996 | 0.00249 |
| Prednisolone | 0.995 | 0.989–1.000 | 0.0679 |
| Pentoxifylline | 0.990 | 0.983–0.996 | 0.00171 |
| Prednisolone and pentoxifylline | 0.990 | 0.983–0.997 | 0.00778 |
The odds ratios with their corresponding 95% confidence intervals for the different treatment arms of the STOPAH trial (2 × 2 factorial design) are presented.